Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

Share Price is delayed by 15 minutes
Get Live Data
0.546    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.05 (9.091%)
Market Cap: £3.17m
FUM Live PriceLast checked at - London Stock Exchange

Intraday Futura Medical Share Chart

Holding(s) in Company

23 Jan 2019 17:38

RNS Number : 9352N
Futura Medical PLC
23 January 2019
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Futura Medical PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

x

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Lombard Odier Asset Management (Europe) Limited

City and country of registered office (if applicable)

London, United-Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

Disclosure on behalf of accounts managed on a discretionary basis by Lombard Odier Investment Managers group.

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

22/01/2019

6. Date on which issuer notified (DD/MM/YYYY):

23/01/2019

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

21.79%

21.79%

204,660,267.00

Position of previous notification (if

applicable)

22.96%

22.96%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0033278473

44,455,631

21.72%

SUBTOTAL 8. A

44,455,631

21.72%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

x

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

London, United-Kingdom

Date of completion

23/01/2019

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLEAXFDADXNEFF
Date   Source Headline
20th Sep 20184:35 pmRNSPrice Monitoring Extension
19th Sep 20189:05 amRNSSecond Price Monitoring Extn
19th Sep 20189:00 amRNSPrice Monitoring Extension
19th Sep 20187:00 amRNSBusiness Update
29th Aug 20187:00 amRNSNotice of Interim Results
23rd Jul 20187:00 amRNSTPR 100: UK Regulatory Submission
13th Jun 20186:22 pmRNSResult of AGM
13th Jun 20187:00 amRNSAGM Statement
31st May 20186:20 pmRNSTotal Voting Rights
30th May 201810:20 amRNSBlock Listing Interim Review
25th May 20187:00 amRNSApplication for Block Listing
27th Apr 20185:11 pmRNSNotification of Major Interest in Shares
26th Apr 20187:00 amRNSPhase III efficacy study of MED2002
25th Apr 20187:00 amRNSPositive data from MED2002 PK study
6th Apr 201812:13 pmRNSNotice of AGM
14th Mar 20187:00 amRNSPreliminary Results
13th Mar 20187:00 amRNSPositive Interim Data from MED2002 PK study
20th Feb 20187:00 amRNSDirectorate Changes
15th Feb 20187:00 amRNSNotification of Preliminary Results
31st Jan 201810:39 amRNSTotal Voting Rights
4th Jan 20187:00 amRNSPublication of Positive MED2002 Clinical Data
3rd Jan 20183:08 pmRNSDirector/PDMR Shareholding
2nd Jan 20183:50 pmRNSRemuneration of Non-Executive Directors and TVR
29th Nov 20177:00 amRNSMED2002: Regulatory, Clinical & Commercial Update
29th Nov 20177:00 amRNSMED2002: PK Study Commences
24th Nov 20171:08 pmRNSBlock Listing Update
23rd Oct 20173:30 pmRNSPDMR Dealing
16th Oct 20177:00 amRNSFurther Positive Market Research Data for MED2002
13th Sep 20177:00 amRNSDirectors' / PDMR Dealing and Grant of Options
12th Sep 20177:00 amRNSInterim Results
1st Sep 201712:24 pmRNSNotification of Major Interest in Shares
23rd Aug 201710:32 amRNSCSD500: Termination of Licensing Agreement
22nd Aug 20173:59 pmRNSNotification of Half Year Results
4th Jul 20177:00 amRNSInvestor Presentation on MED2002
14th Jun 20175:00 pmRNSResult of AGM
14th Jun 20177:00 amRNSAGM Statement
31st May 20177:00 amRNSMED2002 Regulatory Update
31st May 20177:00 amRNSTotal Voting Rights
22nd May 20177:00 amRNSBlock Listing Update
20th Apr 20179:45 amRNSNotice of AGM
4th Apr 201712:11 pmRNSNotification of Major Interest in Shares
4th Apr 201712:10 pmRNSNotification of Major Interest in Shares
23rd Mar 20177:00 amRNSPreliminary Results
22nd Mar 20177:00 amRNSLicenses CSD500 in Portugal
6th Mar 20177:00 amRNSResearch Confirms MED2002's US$1 Billion Potential
6th Mar 20177:00 amRNSMED2002 Additional Patent Filing
23rd Jan 20171:00 pmRNSNotice of Preliminary Results
18th Jan 20174:30 pmRNSDirector's dealings
13th Jan 20175:45 pmRNSDirector / PDMR Dealing and Grant of Options
12th Jan 20173:00 pmRNSDirector / PDMR Dealing and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.